Featured News

NIH and GW University recruiting volunteers for monkeypox vaccine trials
Check out this interview with our very own Dr. Diemert, the director of the GW Vaccine Research Unit on WTOP to learn more about our current monkeypox trial.
Clinical Trial Evaluating Monkeypox Vaccine Begins
NIH Trial is Evaluating Intradermal Delivery to Expand the Vaccine Supply.
Americans likely to need COVID-19 booster, officials say, but questions abound
Dr. Diemert and other infectious disease experts discuss the search for a universal COVID-19 vaccine and comparisons to the seasonal influenza vaccine.
Monkeypox Myths and Facts: What You Need to Know
Doreen Gentzler, NBC4 News Anchor, interviews GW VRU Director, Dr. David Diemert on monkeypox myths and facts.
FDA Clears Moderna, Pfizer Covid Shots for Children 5 and Under
Long-awaited protection for tots appears close to arrival. Moderna also get clearance for vaccine for 6- to 17-year olds.
The Most Common Questions About The Novavax COVID Vaccine, Answered
How is the shot different from Pfizer, Moderna and J&J? Does it work against new variants? Here's what to know.
Moderna Announces Omicron-Containing Bivalent Booster Candidate mRNA-1273.214 Demonstrates Superior Antibody Response Against Omicron
Moderna, Inc., (NASDAQ:MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced new clinical data on its Omicron-containing bivalent COVID booster candidate, mRNA-1273.214, containing mRNA-1273 (Spikevax) and a vaccine candidate targeting the Omicron…
Subscribe to Featured News